GlassScriptPhysician profile
Keenan C Wanamaker
NPI 1972508968
$22,633.49
in general payments reported to CMS, 2019-2025
37 companies · $16K in 2025
The $16K reported for 2025 was more than what 93% of Vascular Surgery providers received nationally (typical 2025 total: $927).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,015 · 2020: $96.23 · 2021: $427 · 2022: $755 · 2023: $262 · 2024: $3,941 · 2025: $16K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Long Term Medical Supply Or Device Loan: $16K · Food and Beverage: $4,254 · Travel and Lodging: $545.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Long Term Medical Supply Or Device Loan | $15,541.67 |
| Food and Beverage | $4,254.08 |
| Travel and Lodging | $544.94 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Angiodynamics, INC. | $15,747.98 | 2024-2025 | Auryon Laser System 100-120 Vac, Auryon Laser System 100-120 Vac |
| Abbott Laboratories | $2,468.82 | 2019-2025 | Perclose Proglide, Cardiomems, Emboshield Nav6 |
| Cvrx, INC. | $1,359.47 | 2024-2025 | Barostim Neo System |
| Endologix LLC | $713.47 | 2022-2023 | |
| Philips North America LLC | $398.31 | 2019-2021 | |
| Boston Scientific Corporation | $210.94 | 2019-2024 | Lux-Dx Insertable Cardiac Monitor, Varithena Administration Pack |
| Novartis Pharmaceuticals Corporation | $155.10 | 2024-2025 | |
| E.R. Squibb & Sons, L.L.C. | $131.75 | 2021-2024 | Camzyos |
| Cordis US Corp. | $109.90 | 2024 | Mynx Control |
| Medtronic, INC. | $108.54 | 2021 | |
| Bard Peripheral Vascular, INC. | $108.05 | 2019-2021 | |
| W. L. Gore & Associates, INC. | $108.05 | 2024 | Excluder Conformable Aaa Endoprosthesis With Active Control |
| Biosense Webster, INC. | $105.11 | 2024 | Carto 3 |
| Organogenesis INC. | $101.10 | 2021-2022 | |
| Ekos Corporation | $81.34 | 2019 |
Show all 37 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic Vascular, INC. | $79.77 | 2020 | |
| Biotronik INC. | $79.47 | 2025 | Biomonitor |
| Lemaitre Vascular, INC. | $61.49 | 2022-2023 | Artegraft Vascular Graft |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $56.76 | 2019 | |
| Janssen Pharmaceuticals, INC | $42.86 | 2019 | |
| Davol INC. | $38.12 | 2022 | |
| Zimmer Biomet Holdings, INC. | $37.81 | 2022 | |
| Tactile Systems Technology INC | $36.49 | 2024 | Flexitouch Plus, Entre Plus |
| Silk Road Medical, INC. | $34.89 | 2022 | |
| Amgen INC. | $32.36 | 2025 | Repatha, Repatha |
| Kestra Medical Technology Services, INC. | $28.98 | 2025 | Assure Wcd |
| Penumbra, INC. | $25.00 | 2022 | |
| Actelion Pharmaceuticals US, INC. | $24.92 | 2024 | Opsumit |
| Takeda Pharmaceuticals U.S.A., INC. | $24.10 | 2022 | |
| Abiomed | $19.04 | 2024 | Impella |
| Smith+Nephew, INC. | $16.23 | 2021 | |
| Getinge USA Sales, LLC | $16.03 | 2019 | |
| Cardinal Health 200 LLC | $15.29 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $14.77 | 2022 | |
| Intuitive Surgical, INC. | $14.57 | 2023 | Da Vinci Surgical System |
| Abbvie INC. | $14.55 | 2022 | |
| Innocoll Pharmaceuticals Limited | $12.06 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Keenan Wanamaker listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.